OQS
SGMO

Occudo Quantitative Strategies’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Occudo Quantitative Strategies’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-26,016
Closed -$195K – 1305
2021
Q4 		$195K Buy
+26,016
New +$226K 0.02% 900
2021
Q1 		– Sell
-11,723
Closed -$183K – 910
2020
Q4 		$183K Buy
+11,723
New +$137K 0.06% 556

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Occudo Quantitative Strategies's SGMO Position: Q1 2022 in Review

Occudo Quantitative Strategies sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2022, closing a stake of 26,016 shares — an estimated $195K sold.

Occudo Quantitative Strategies first reported a position in SGMO in Q4 2020 and held it in 2 quarters. The position peaked at $195K in Q4 2021. 195 funds tracked by Wall St. Rank hold SGMO as of Q1 2022.

  • Occudo Quantitative Strategies reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 26,016 SANGAMO THERAPEUTICS INC shares in Q1 2022, an estimated $195K.
  • Occudo Quantitative Strategies first reported a position in SANGAMO THERAPEUTICS INC in Q4 2020 and held it in 2 quarters.
  • Occudo Quantitative Strategies's SANGAMO THERAPEUTICS INC position peaked at $195K in Q4 2021.
  • 195 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.